Clinical Trial Update: Open-Label, Non Randomized Phase 2 Study With Safety Run-In [Phase 2]

View source ↗

Summary

Open-label Phase 2 study with safety run-in for lymphoma; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma Malignant

Snippet

Sponsor: PIQUR Therapeutics AG | Conditions: Lymphoma, Malignant | Phase 2 | Status: COMPLETED